Memphasys Ltd (AU:MEM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Memphasys Ltd has extended its Share Purchase Plan closing date to October 31, 2024, following shareholder feedback requesting more time to consider the offer. The initiative aims to raise up to $3 million, funding projects like the Felix clinical trial and equine fertility study. This extension provides investors additional opportunities to engage with Memphasys’ promising biotechnology advancements.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
